BillionToOne, Inc.
BLLN - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.35B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $5.35 Billion |
|---|---|
| Enterprise Value | $4.95 Billion |
| Earnings per Share | $0.06 |
| Beta | 0.34 |
| Outstanding Shares | 46,403,350 |
Return
| Return on Equity | 6.24% |
|---|---|
| Return on Assets | 4.59% |
| Return on Invested Capital | 6.13% |
Valuation & Multiples
| P/E Ratio | 164.21 |
|---|---|
| PEG | -4.87 |
| Price to Sales | 14.24 |
| Price to Book Ratio | 10.35 |
| Enterprise Value to Revenue | 12.44 |
| Enterprise Value to EBIT | 119.75 |
| Enterprise Value to Net Income | 147 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.27 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 4, 2026
EPS Estimate
$0.15
Consensus analyst estimateRevenue Estimate
$115.80 M
Consensus analyst estimateNext Earnings Call
Expected Date
March 3, 2027
EPS Estimate
$0.16
Consensus analyst estimateRevenue Estimate
$121.12 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 111.30% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.08%▼ 33.10% |
|---|---|
| Total Invested | $3.87M▼ 99.79% |
| Investors Holding | 11▼ 153.00% |
About BillionToOne, Inc.
620 employees
CEO: Oguzhan Atay
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to...